BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liaw YF, Tai DI, Chu CM, Pao CC, Chen TJ. Acute exacerbation in chronic type B hepatitis: Comparison between HBeAg and antibody-positive patients. Hepatology. 1987;7:20-23. [PMID: 2433203 DOI: 10.1002/hep.1840070106] [Cited by in Crossref: 112] [Cited by in F6Publishing: 96] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Chu CM, Liaw YF, Pao CC, Huang MJ. The etiology of acute hepatitis superimposed upon previously unrecognized asymptomatic HBsAg carriers. Hepatology 1989;9:452-6. [PMID: 2493416 DOI: 10.1002/hep.1840090319] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
2 Liaw Y, Chien R, Yeh C, Tsai S, Chu C. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology 1999;30:567-72. [DOI: 10.1002/hep.510300221] [Cited by in Crossref: 384] [Cited by in F6Publishing: 343] [Article Influence: 17.5] [Reference Citation Analysis]
3 Nguyen K, Pan C, Xia V, Hu J, Hu KQ. Clinical course of chronic hepatitis B (CHB) presented with normal ALT in Asian American patients. J Viral Hepat 2015;22:809-16. [PMID: 25611883 DOI: 10.1111/jvh.12388] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chang ML, Liaw YF. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management. J Hepatol. 2014;61:1407-1417. [PMID: 25178562 DOI: 10.1016/j.jhep.2014.08.033] [Cited by in Crossref: 147] [Cited by in F6Publishing: 126] [Article Influence: 21.0] [Reference Citation Analysis]
5 Mels GC, Bellati G, Leandro G, Brunetto MR, Vicari O, Borzio M, Piantino P, Fornaciari G, Scudeller G, Angeli G. Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver. 1994;14:175-181. [PMID: 7968277 DOI: 10.1111/j.1600-0676.1994.tb00071.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 1.5] [Reference Citation Analysis]
6 Tsang SW, Chan HL, Leung NW, Chau TN, Lai ST, Chan FK, Sung JJ. Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection. Aliment Pharmacol Ther. 2001;15:1737-1744. [PMID: 11683687 DOI: 10.1046/j.1365-2036.2001.01107.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chu CM, Shyu WC, Liaw YF. Comparative studies on expression of alpha-smooth muscle actin in hepatic stellate cells in chronic hepatitis B and C. Dig Dis Sci. 2008;53:1364-1369. [PMID: 17934809 DOI: 10.1007/s10620-007-9997-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
8 Yuan HJ, Yuen MF, Wong DK, Sum SM, Doutreloigne J, Sablon E, Lai CL. Determinants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearance. J Clin Microbiol 2005;43:1594-9. [PMID: 15814971 DOI: 10.1128/JCM.43.4.1594-1599.2005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Wang S, Lu R, Lee F, Chao Y, Huang Y, Chen C, Lee S. Utility of lentil lectin affinity of α-fetoprotein in the diagnosis of hepatocellular carcinoma. Journal of Hepatology 1996;25:166-71. [DOI: 10.1016/s0168-8278(96)80069-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
10 Honkoop P, de Man RA, Niesters HG, Zondervan PE, Schalm SW. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy. Hepatology. 2000;32:635-639. [PMID: 10960461 DOI: 10.1053/jhep.2000.16333] [Cited by in Crossref: 165] [Cited by in F6Publishing: 138] [Article Influence: 7.9] [Reference Citation Analysis]
11 Liaw YF, Dong JT, Chiu KW, Sheen IS, Chu CM. Why most patients with hepatitis delta virus infection are seronegative for hepatitis B e antigen. A prospective controlled study. J Hepatol 1991;12:106-9. [PMID: 2007766 DOI: 10.1016/0168-8278(91)90918-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
12 Tai DI, Lo SK, Kuo CH, Du JM, Chen CJ, Hung CS, Chu CM. Replication of hepatitis B in HBsAg-positive siblings. J Viral Hepat. 2002;9:272-279. [PMID: 12081604 DOI: 10.1046/j.1365-2893.2002.00353.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
13 Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507-539. [PMID: 17256718 DOI: 10.1002/hep.21513] [Cited by in Crossref: 1675] [Cited by in F6Publishing: 1450] [Article Influence: 119.6] [Reference Citation Analysis]
14 Chu C, Liaw Y, Sheen I, Chen T. Intrahepatic expression of HBcAg and delta antigen in anti-HBe positive HBsAg carriers with acute exacerbation or chronic active liver disease. J Med Virol 1990;30:181-6. [DOI: 10.1002/jmv.1890300307] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
15 Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology. 1991;100:182-188. [PMID: 1983820 DOI: 10.1016/0016-5085(91)90599-g] [Cited by in Crossref: 616] [Cited by in F6Publishing: 161] [Article Influence: 20.5] [Reference Citation Analysis]
16 Thomas HC, Karayiannis P, Brook G. Treatment of hepatitis B virus infection with interferon. Factors predicting response to interferon. J Hepatol 1991;13 Suppl 1:S4-7. [PMID: 1960378 DOI: 10.1016/0168-8278(91)91712-p] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
17 Kao J. Clinical relevance of hepatitis B viral genotypes: A case of déjà vu? Journal of Gastroenterology and Hepatology 2002;17:113-5. [DOI: 10.1046/j.1440-1746.2002.02623.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
18 Gayno S, Marcellin P, Loriot M, Martinot-peignoux M, Levy P, Erlinger S, Benhamou J. Detection of serum HBV-DNA by polymerase chain reaction (PCR) in patients before reactivation of chronic hepatitis B. Journal of Hepatology 1992;14:357-60. [DOI: 10.1016/0168-8278(92)90183-p] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
19 Schalm SW, van Wijngaarden JK. Doctor-to-patient transmission of viral hepatitis B: is it a problem, is there a solution? J Viral Hepat 2000;7:245-9. [PMID: 10886532 DOI: 10.1046/j.1365-2893.2000.00239.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
20 Chen YC, Hsu CW, Chang MY, Yeh CT. On-treatment mortality predictors in chronic hepatitis B patients experiencing severe acute exacerbation: a prospective observational study. BMC Res Notes. 2013;6:349. [PMID: 24004574 DOI: 10.1186/1756-0500-6-349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
21 Takeda K, Akahane Y, Suzuki H, Okamoto H, Tsuda F, Miyakawa Y, Mayumi M. Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy. Hepatology 1990;12:1284-9. [DOI: 10.1002/hep.1840120606] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 2.2] [Reference Citation Analysis]
22 Liaw Y, Chien R, Sheen I, Lin D, Lin H, Chu C. Hepatitis C virus infection in patients with chronic liver diseases in an endemic area for hepatitis B virus infection. Gastroenterol Jpn 1991;26:167-9. [DOI: 10.1007/bf02779291] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Tai DI, Tsay PK, Jeng WJ, Weng CC, Huang SF, Huang CH, Lin SM, Chiu CT, Chen WT, Wan YL. Differences in liver fibrosis between patients with chronic hepatitis B and C: evaluation by acoustic radiation force impulse measurements at 2 locations. J Ultrasound Med 2015;34:813-21. [PMID: 25911714 DOI: 10.7863/ultra.34.5.813] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
24 Chan HL, Lok AS. HEPATITIS B IN ADULTS. Clinics in Liver Disease 1999;3:291-307. [DOI: 10.1016/s1089-3261(05)70069-6] [Cited by in Crossref: 10] [Article Influence: 0.5] [Reference Citation Analysis]
25 Yeo W, Chan PK, Hui P, Ho WM, Lam KC, Kwan WH, Zhong S, Johnson PJ. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study. J Med Virol. 2003;70:553-561. [PMID: 12794717 DOI: 10.1002/jmv.10430] [Cited by in Crossref: 149] [Cited by in F6Publishing: 135] [Article Influence: 8.3] [Reference Citation Analysis]
26 Wu JC, Chen CM, Sheen IJ, Lee SD, Tzeng HM, Choo KB. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology. 1995;22:1656-1660. [PMID: 7489970 DOI: 10.1002/hep.1840220607] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
27 Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA; Hepatitis B Research Network. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection. Clin Gastroenterol Hepatol 2019;17:2541-2551.e2. [PMID: 30743006 DOI: 10.1016/j.cgh.2019.02.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
28 Sheen I, Liaw Y, Lin D, Chu C. Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study. Journal of Hepatology 1996;24:525-31. [DOI: 10.1016/s0168-8278(96)80136-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
29 Yuan L, Zeng BM, Liu LL, Ren Y, Yang YQ, Chu J, Li Y, Yang FW, He YH, Lin SD. Risk factors for progression to acute-on-chronic liver failure during severe acute exacerbation of chronic hepatitis B virus infection. World J Gastroenterol 2019;25:2327-37. [PMID: 31148904 DOI: 10.3748/wjg.v25.i19.2327] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
30 Chu CM, Yeh CT, Lee CS, Sheen IS, Liaw YF. Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion. J Clin Microbiol. 2002;40:16-21. [PMID: 11773086 DOI: 10.1128/jcm.40.1.16-21.2002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
31 Van Damme P, Ward JW, Shouval D, Zanetti A. Hepatitis B Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 342-374.e17. [DOI: 10.1016/b978-0-323-35761-6.00025-0] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
32 Chan HL, Hui Y, Leung NW, Ching JY, Chan FK, Sung JJ. Risk Factors for Active Liver Disease in Hbeag-Negative Chronic Hepatitis B Virus–Infected Patients. American Journal of Gastroenterology 2000;95:3547-51. [DOI: 10.1111/j.1572-0241.2000.03373.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
33 Chan HL, Tsang SW, Wong ML, Tse CH, Leung NW, Chan FK, Sung JJ. Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong. Am J Gastroenterol. 2002;97:2629-2633. [PMID: 12385451 DOI: 10.1111/j.1572-0241.2002.06065.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
34 Peng CW, Jeng WJ. Understanding More About Hepatitis Flare in Chronic Hepatitis B Patients. Clin Gastroenterol Hepatol 2020;18:266-7. [PMID: 31265807 DOI: 10.1016/j.cgh.2019.05.053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Seelig R, Renz M, Seelig HP. PCR in the Diagnosis of Viral Hepatitis. Annals of Medicine 2009;24:225-30. [DOI: 10.3109/07853899209147827] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
36 Liu X, Schinazi RF. Hepatitis B virus resistance to lamivudine and its clinical implications. Antivir Chem Chemother. 2002;13:143-155. [PMID: 12448687 DOI: 10.1177/095632020201300301] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
37 Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology. 1995;22:1101-1108. [PMID: 7557857 DOI: 10.1002/hep.1840220413] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
38 Niederau C. Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit. World J Gastroenterol 2014;20:11595-617. [PMID: 25206267 DOI: 10.3748/wjg.v20.i33.11595] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
39 Lok AS, Lai CL. Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. J Hepatol. 1990;10:29-34. [PMID: 2307827 DOI: 10.1016/0168-8278(90)90069-4] [Cited by in Crossref: 164] [Cited by in F6Publishing: 146] [Article Influence: 5.3] [Reference Citation Analysis]
40 Liaw YF. Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection. Nat Rev Gastroenterol Hepatol. 2019;16:631-641. [PMID: 31477873 DOI: 10.1038/s41575-019-0197-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
41 Yeo W, Chan PK, Zhong S, Ho WM, Steinberg JL, Tam JS, Hui P, Leung NW, Zee B, Johnson PJ. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol. 2000;62:299-307. [PMID: 11055239 DOI: 10.1002/1096-9071(200011)62:3%3C299::AID-JMV1%3E3.0.CO;2-0] [Reference Citation Analysis]
42 Rawal B, Parida S, Watkins R, Ghosh P, Smith H. Symptomatic reactivation of hepatitis B in pregnancy. The Lancet 1991;337:364. [DOI: 10.1016/0140-6736(91)90993-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
43 Chu CM, Hung SJ, Lin J, Tai DI, Liaw YF. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med. 2004;116:829-834. [PMID: 15178498 DOI: 10.1016/j.amjmed.2003.12.040] [Cited by in Crossref: 199] [Cited by in F6Publishing: 170] [Article Influence: 11.7] [Reference Citation Analysis]
44 Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, Dokmeci AK, Gane E, Hou JL, Jafri W, Jia J, Kim JH, Lai CL, Lee HC, Lim SG, Liu CJ, Locarnini S, Al Mahtab M, Mohamed R, Omata M, Park J, Piratvisuth T, Sharma BC, Sollano J, Wang FS, Wei L, Yuen MF, Zheng SS, Kao JH. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1-98. [PMID: 26563120 DOI: 10.1007/s12072-015-9675-4] [Cited by in Crossref: 1076] [Cited by in F6Publishing: 935] [Article Influence: 179.3] [Reference Citation Analysis]
45 Yeo W, Chan PK, Zhong S, Ho WM, Steinberg JL, Tam JS, Hui P, Leung NW, Zee B, Johnson PJ. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 2000;62:299-307. [PMID: 11055239 DOI: 10.1002/1096-9071(200011)62:3<299::aid-jmv1>3.0.co;2-0] [Cited by in Crossref: 423] [Cited by in F6Publishing: 148] [Article Influence: 21.2] [Reference Citation Analysis]
46 Liaw YF, Lin DY, Chen TJ, Chu CM. Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Liver. 1989;9:235-241. [PMID: 2770436 DOI: 10.1111/j.1600-0676.1989.tb00405.x] [Cited by in Crossref: 109] [Cited by in F6Publishing: 100] [Article Influence: 3.4] [Reference Citation Analysis]
47 Sarin SK, Satapathy SK, Chauhan R. Hepatitis B e-antigen negative chronic hepatitis B. J Gastroenterol Hepatol 2002;17 Suppl 3:S311-21. [PMID: 12472956 DOI: 10.1046/j.1440-1746.17.s3.20.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
48 Brook MG, Karayiannis P, Thomas HC. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors. Hepatology. 1989;10:761-763. [PMID: 2680866 DOI: 10.1002/hep.1840100502] [Cited by in Crossref: 225] [Cited by in F6Publishing: 200] [Article Influence: 7.0] [Reference Citation Analysis]
49 Brissot P, Jacquelinet C, Jouanolle H, David V, Guyader D, Guéguen M, Blayau M, Lescoat G, Messner M, Deugnier Y. Short-term prednisolone followed by recombinant human α-interferon alone or combined with adenine-arabinoside in chronic hepatitis B. Journal of Hepatology 1991;12:181-9. [DOI: 10.1016/0168-8278(91)90936-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
50 Colloredo Mels G, Bellati G, Leandro G, Brunetto MR, Vicari O, Piantino P, Borzio M, Angeli G, Ideo G, Bonino F. Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations. Arch Virol Suppl 1993;8:203-11. [PMID: 8260865 DOI: 10.1007/978-3-7091-9312-9_20] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
51 Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology. Japan Society of Hepatology Guidelines for the Management of Hepatitis B Virus Infection: 2019 update. Hepatol Res 2020;50:892-923. [PMID: 32343469 DOI: 10.1111/hepr.13504] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
52 Vaillant A. Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure. Viruses 2021;13:745. [PMID: 33922828 DOI: 10.3390/v13050745] [Reference Citation Analysis]
53 Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc. 2007;82:967-975. [PMID: 17673066 DOI: 10.4065/82.8.967] [Cited by in Crossref: 134] [Cited by in F6Publishing: 106] [Article Influence: 9.6] [Reference Citation Analysis]
54 Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology. JSH Guidelines for the Management of Hepatitis B Virus Infection. Hepatol Res. 2014;44 Suppl S1:1-58. [PMID: 24397839 DOI: 10.1111/hepr.12269] [Cited by in Crossref: 103] [Cited by in F6Publishing: 88] [Article Influence: 14.7] [Reference Citation Analysis]
55 Taketa K. Alpha-fetoprotein: reevaluation in hepatology. Hepatology 1990;12:1420-32. [PMID: 1701754 DOI: 10.1002/hep.1840120625] [Cited by in Crossref: 254] [Cited by in F6Publishing: 217] [Article Influence: 8.5] [Reference Citation Analysis]
56 Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, Hsu WC, Huang CC, Wang SS, Lo KJ. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol. 1995;22:165-172. [PMID: 7790704 DOI: 10.1016/0168-8278(95)80424-2] [Cited by in Crossref: 231] [Cited by in F6Publishing: 216] [Article Influence: 8.9] [Reference Citation Analysis]
57 Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology. 1988;8:493-496. [PMID: 3371868 DOI: 10.1002/hep.1840080310] [Cited by in Crossref: 414] [Cited by in F6Publishing: 378] [Article Influence: 12.5] [Reference Citation Analysis]
58 Tu T, Mason WS, Clouston AD, Shackel NA, McCaughan GW, Yeh MM, Schiff ER, Ruszkiewicz AR, Chen JW, Harley HA, Stroeher UH, Jilbert AR. Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection. J Viral Hepat. 2015;22:737-753. [PMID: 25619231 DOI: 10.1111/jvh.12380] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 8.2] [Reference Citation Analysis]
59 Chien RN, Lin CH, Liaw YF. The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B. J Hepatol. 2003;38:322-327. [PMID: 12586298 DOI: 10.1016/s0168-8278(02)00419-1] [Cited by in Crossref: 79] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
60 Lin H, Liaw Y, Chen T, Chu C, Huang M. Natural course of patients with chronic type B hepatitis following acute hepatitis delta virus superinfection. Liver 1989;9:129-34. [DOI: 10.1111/j.1600-0676.1989.tb00389.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
61 Yeo W, Zhong S, Chan PKS, Ho WM, Wong HTM, Chan ASK, Johnson PJ. Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy. J Viral Hepat 2000;7:448-58. [DOI: 10.1046/j.1365-2893.2000.00257.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
62 Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol. 1997;12:747-751. [PMID: 9430041 DOI: 10.1111/j.1440-1746.1997.tb00364.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 2.5] [Reference Citation Analysis]
63 Liaw Y, Pao C, Chu C. Changes of serum HBV-DNA in relation to serum transaminase level during acute exacerbation in patients with chronic type B hepatitis. Liver 1988;8:231-5. [DOI: 10.1111/j.1600-0676.1988.tb00998.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
64 Chi H, Arends P, Reijnders JGP, Carey I, Brown A, Fasano M, Mutimer D, Deterding K, Oo YH, Petersen J, van Bommel F, de Knegt RJ, Santantonio TA, Berg T, Welzel TM, Wedemeyer H, Buti M, Pradat P, Zoulim F, Hansen BE, Janssen HLA; for the VIRGIL Surveillance Study Group (European surveillance network for vigilance against viral resistance). Flares during long-term entecavir therapy in chronic hepatitis B: Flares during entecavir. Journal of Gastroenterology and Hepatology 2016;31:1882-7. [DOI: 10.1111/jgh.13377] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
65 ter Borg MJ, Leemans WF, de Man RA, Janssen HL. Exacerbation of chronic hepatitis B infection after delivery. J Viral Hepat. 2008;15:37-41. [PMID: 18088243 DOI: 10.1111/j.1365-2893.2007.00894.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 48] [Article Influence: 1.3] [Reference Citation Analysis]
66 Tsai WL, Sun WC, Cheng JS. Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. Int J Mol Sci. 2015;16:28126-28145. [PMID: 26703566 DOI: 10.3390/ijms161226087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
67 Yeo W, Zee B, Zhong S, Chan PK, Wong WL, Ho WM, Lam KC, Johnson PJ. Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br J Cancer. 2004;90:1306-1311. [PMID: 15054446 DOI: 10.1038/sj.bjc.6601699] [Cited by in Crossref: 218] [Cited by in F6Publishing: 206] [Article Influence: 12.8] [Reference Citation Analysis]
68 Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, Chan H, Chan FK, Sung JJ, Chan HL. Evaluation of Alanine Transaminase and Hepatitis B Virus DNA to Predict Liver Cirrhosis in Hepatitis B e Antigen-Negative Chronic Hepatitis B Using Transient Elastography. The American Journal of Gastroenterology 2008;103:3071-81. [DOI: 10.1111/j.1572-0241.2008.02157.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
69 Ren Y, Liu L, Li Y, Yang F, He Y, Zhu Y, Hu X, Lin S. Development and validation of a scoring system to predict progression to acute-on-chronic liver failure in patients with acute exacerbation of chronic hepatitis B. Hepatol Res. 2018;48:692-700. [PMID: 29336092 DOI: 10.1111/hepr.13062] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
70 Papatheodoridis GV, Hadziyannis SJ. Diagnosis and management of pre-core mutant chronic hepatitis B. J Viral Hepat. 2001;8:311-321. [PMID: 11555188 DOI: 10.1046/j.1365-2893.2001.00303.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 3.6] [Reference Citation Analysis]
71 Charbel H, Lewis JH. Hepatitis B Reactivation in the Setting of Chemotherapy and Immunosuppression. In: Shetty K, Wu GY, editors. Chronic Viral Hepatitis. Totowa: Humana Press; 2010. pp. 307-36. [DOI: 10.1007/978-1-59745-565-7_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Chan HL, Wong GL, Tse CH, Chan HY, Wong VW. Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients. J Infect Dis. 2011;204:408-414. [PMID: 21742839 DOI: 10.1093/infdis/jir283] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 7.8] [Reference Citation Analysis]
73 Tran TT, Martin P. Hepatitis B: epidemiology and natural history. Clin Liver Dis. 2004;8:255-266. [PMID: 15481339 DOI: 10.1016/j.cld.2004.02.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
74 Chen YC, Chu CM, Yeh CT, Liaw YF. Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study. Hepatol Int. 2007;1:267-273. [PMID: 19669348 DOI: 10.1007/s12072-007-5001-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 6.8] [Reference Citation Analysis]
75 Liaw YF. Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy. J Gastroenterol Hepatol. 2003;18:246-252. [PMID: 12603523 DOI: 10.1046/j.1440-1746.2003.02976.x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 106] [Article Influence: 6.2] [Reference Citation Analysis]
76 Yang F, Liu Y, Zeng B, Chu J, Hu H, Yang Y, Chen H, Tian C, Li Y, Lin S. Noninvasive assessment of liver fibrosis for predicting acute-on-chronic liver failure in patients with chronic hepatitis B. Hepatol Int 2021;15:593-601. [PMID: 33389677 DOI: 10.1007/s12072-020-10106-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Lega L, Vierucci A, Blumberg B, Saracco G, Rizzetto M, Zhu M, Feitelson M. Hepatitis B x antigen and polymerase antibodies in the serum of hepatitis B carriers with or without hepatitis delta virus infection. Journal of Hepatology 1992;14:286-93. [DOI: 10.1016/0168-8278(92)90172-l] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
78 Puri P. Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B. J Clin Exp Hepatol 2013;3:301-12. [PMID: 25755518 DOI: 10.1016/j.jceh.2013.08.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
79 Lee CM, Ong GY, Lu SN, Wang JH, Liao CA, Tung HD, Chen TM, Changchien CS. Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation. J Hepatol. 2002;37:669-674. [PMID: 12399235 DOI: 10.1016/s0168-8278(02)00267-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
80 Fung J, Lai C, Seto W, Yuen M. Emerging drugs for the treatment of hepatitis B. Expert Opinion on Emerging Drugs 2016;21:183-93. [DOI: 10.1517/14728214.2016.1162155] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
81 Chen TJ, Liaw YF. The prognostic significance of bridging hepatic necrosis in chronic type B hepatitis: a histopathologic study. Liver. 1988;8:10-16. [PMID: 3367703 DOI: 10.1111/j.1600-0676.1988.tb00960.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
82 Jeng WJ, Sheen IS, Liaw YF. Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B. Clin Gastroenterol Hepatol. 2010;8:541-545. [PMID: 20298811 DOI: 10.1016/j.cgh.2010.02.023] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
83 Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol. 2002;17:643-650. [PMID: 12100608 DOI: 10.1046/j.1440-1746.2002.02737.x] [Cited by in Crossref: 222] [Cited by in F6Publishing: 211] [Article Influence: 11.7] [Reference Citation Analysis]
84 Massoumi H, Martin P, Tan H. Management of chronic hepatitis B: . European Journal of Gastroenterology & Hepatology 2011;23:642-50. [DOI: 10.1097/meg.0b013e3283474add] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
85 Liaw Y, Chien R, Chen T, Sheen I, Chu C. Concurrent hepatitis C virus and hepatitis delta virus superinfection in patients with chronic hepatitis B virus infection. J Med Virol 1992;37:294-7. [DOI: 10.1002/jmv.1890370411] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 0.8] [Reference Citation Analysis]
86 Zhang N, Reijnders JGP, Perquin M, Hansen BE, Janssen HLA. Frequency and clinical outcomes of flares related to nucleos(t)ide analogue therapy in patients with chronic hepatitis B. Journal of Viral Hepatitis 2011;18. [DOI: 10.1111/j.1365-2893.2011.01448.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
87 Wong VW, Chan HL. Severe acute exacerbation of chronic hepatitis B: A unique presentation of a common disease. J Gastroenterol Hepatol. 2009;24:1179-1186. [PMID: 19682192 DOI: 10.1111/j.1440-1746.2009.05924.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
88 Liaw Y. Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B: Management of YMDD mutations. Journal of Gastroenterology and Hepatology 2002;17:S333-7. [DOI: 10.1046/j.1440-1746.17.s3.23.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
89 Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002;2:395-403. [PMID: 12127351 DOI: 10.1016/s1473-3099(02)00315-8] [Cited by in Crossref: 555] [Cited by in F6Publishing: 186] [Article Influence: 29.2] [Reference Citation Analysis]
90 Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK. Predictive Factors for Early HBeAg Seroconversion in Acute Exacerbation of Patients With HBeAg-Positive Chronic Hepatitis B. Gastroenterology 2009;136:505-12. [DOI: 10.1053/j.gastro.2008.10.089] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
91 Williams SJ, Farrell GC. Serial antipyrine clearance studies detect altered hepatic metabolic function during spontaneous and interferon-induced changes in chronic hepatitis B disease activity. Hepatology 1989;10:192-7. [DOI: 10.1002/hep.1840100212] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
92 Ghany MG, Feld JJ, Chang KM, Chan HLY, Lok ASF, Visvanathan K, Janssen HLA. Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad. Lancet Gastroenterol Hepatol 2020;5:406-17. [PMID: 32057301 DOI: 10.1016/S2468-1253(19)30344-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 11.0] [Reference Citation Analysis]
93 Honkoop P, de Man RA, Heijtink RA, Schalm SW. Hepatitis B reactivation after lamivudine. Lancet. 1995;346:1156-1157. [PMID: 7475613 DOI: 10.1016/s0140-6736(95)91829-9] [Cited by in Crossref: 64] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
94 Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Liaw YF. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology. 2002;35:1522-1527. [PMID: 12029639 DOI: 10.1053/jhep.2002.33638] [Cited by in Crossref: 456] [Cited by in F6Publishing: 399] [Article Influence: 24.0] [Reference Citation Analysis]
95 Chu C, Liaw Y. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat 2007;14:147-52. [DOI: 10.1111/j.1365-2893.2006.00810.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 99] [Article Influence: 7.9] [Reference Citation Analysis]
96 Liaw YF. Hepatitis B Flare After Cessation of Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B: To Retreat or Not to Retreat. Hepatology. 2021;73:843-852. [PMID: 32810321 DOI: 10.1002/hep.31525] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]